Psychiatry Grand Rounds 10/25 | Charles Zorumski, MD
"Preclinical Science & New Treatments in Psychiatry: A Three-Act Play"
About the Speaker:
Charles Zorumski, MD Samuel B. Guze Professor of Psychiatry Professor of Neuroscience Director of the Taylor Family Institute for Innovative Psychiatric Research Co-Director of the Silvio O. Conte Neuroscience Center Washington University-St. Louis School of Medicine
Objectives:
The activity is designed to help the learner:
1. Discuss pathways to new treatments in psychiatry including the role of preclinical neuroscience in treatment development
2. Describe the current state of neurosteroids and oxysterols as treatments in psychiatry
3. Describe the role of repurposing of existing treatments as new therapies in psychiatry and the role of repurposing current psychiatric treatments for medical and neurological illnesses
Summary:
This talk will discuss pathways to new treatments in psychiatry focusing on the role of preclinical neuroscience in the development of neurosteroids and oxysterols. The talk will also discuss repurposing of an approved drug, nitrous oxide, for major depression, and repurposing of a psychiatric medication, fluvoxamine, for COVID-19.
CME/CE credit for Psychiatry Grand Rounds is only available during the live feed time and for a brief time immediately following. The code for this week's session is displayed at the opening and closing of the meeting
For CME/CE information about this session, please visit:
Sponsored by the Luton Lecture FundDepartment of Psychiatry and Behavioral Sciences and Vanderbilt Brain Institute This educational activity received no commercial support.
